Zota Health Care LImited
Zota Health Care LImited (ZOTA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45 Cr | 47 Cr | 50 Cr | 56 Cr | 67 Cr | 72 Cr | 97 Cr | 104 Cr | 129 Cr | 143 Cr | 163 Cr | 174 Cr |
| Operating expenses (approx.) | 41 Cr | 44 Cr | 51 Cr | 58 Cr | 68 Cr | 78 Cr | 95 Cr | 100 Cr | 123 Cr | 143 Cr | 154 Cr | 185 Cr |
| EBITDA | 4 Cr | 3 Cr | -1 Cr | -1 Cr | -0.87 Cr | -6 Cr | 2 Cr | 4 Cr | 6 Cr | -0.44 Cr | 9 Cr | -12 Cr |
| OPM % | 9.8% | 7.1% | -3.0% | -2.2% | -1.3% | -8.4% | 2.5% | 3.8% | 4.9% | -0.3% | 5.3% | -6.7% |
| Other income | 0.40 Cr | 0.15 Cr | 0.46 Cr | 0.02 Cr | 0.54 Cr | 0.51 Cr | 1 Cr | 0.88 Cr | 2 Cr | 2 Cr | 3 Cr | 2 Cr |
| Interest | 1 Cr | 1 Cr | 2 Cr | 3 Cr | 3 Cr | 2 Cr | 3 Cr | 3 Cr | 4 Cr | 5 Cr | 5 Cr | 6 Cr |
| Depreciation | 5 Cr | 5 Cr | 7 Cr | 8 Cr | 10 Cr | 11 Cr | 14 Cr | 15 Cr | 19 Cr | 22 Cr | 27 Cr | 28 Cr |
| Profit before tax | -1 Cr | -3 Cr | -10 Cr | -12 Cr | -13 Cr | -18 Cr | -14 Cr | -13 Cr | -14 Cr | -26 Cr | -26 Cr | -44 Cr |
| Tax % | -48.8% | -7.5% | 27.2% | -4.6% | 4.0% | -2.5% | 9.9% | -5.3% | -12.6% | -14.2% | 45.3% | -0.7% |
| Net profit | -2 Cr | -3 Cr | -7 Cr | -13 Cr | -12 Cr | -19 Cr | -13 Cr | -14 Cr | -16 Cr | -30 Cr | -14 Cr | -44 Cr |
| EPS (₹) | ₹-0.64 | ₹-1.14 | ₹-2.68 | ₹-4.80 | ₹-4.57 | ₹-6.80 | ₹-4.57 | ₹-4.92 | ₹-5.26 | ₹-9.44 | ₹-4.13 | ₹-12.58 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 95 Cr | 107 Cr | 131 Cr | 140 Cr | 180 Cr | 293 Cr | 539 Cr | Sign in for TTM |
| Operating expenses (approx.) | 91 Cr | 106 Cr | 116 Cr | 133 Cr | 173 Cr | 299 Cr | 520 Cr | Sign in for TTM |
| EBITDA | 5 Cr | 0.62 Cr | 15 Cr | 7 Cr | 8 Cr | -6 Cr | 19 Cr | Sign in for TTM |
| OPM % | 4.7% | 0.6% | 11.3% | 5.2% | 4.2% | -2.0% | 3.4% | Sign in for TTM |
| Other income | 2 Cr | 1 Cr | 2 Cr | 2 Cr | 1 Cr | 2 Cr | 7 Cr | Sign in for TTM |
| Interest | 0.07 Cr | 0.11 Cr | 0.32 Cr | 3 Cr | 5 Cr | 11 Cr | 17 Cr | Sign in for TTM |
| Depreciation | 2 Cr | 3 Cr | 4 Cr | 12 Cr | 20 Cr | 43 Cr | 82 Cr | Sign in for TTM |
| Profit before tax | 4 Cr | -0.37 Cr | 12 Cr | -5 Cr | -16 Cr | -58 Cr | -80 Cr | Sign in for TTM |
| Tax % | 29.0% | 42.8% | 28.4% | -23.1% | 11.2% | 1.6% | 7.2% | Sign in for TTM |
| Net profit | 3 Cr | -0.21 Cr | 9 Cr | -6 Cr | -14 Cr | -57 Cr | -74 Cr | Sign in for TTM |
| EPS (₹) | ₹1.12 | ₹-0.09 | ₹3.58 | ₹-2.29 | ₹-5.59 | ₹-20.68 | ₹-22.46 | Sign in for TTM |
| Dividend payout % | — | — | 28.2% | — | — | — | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 25 Cr | 25 Cr | 25 Cr | 25 Cr | 26 Cr | 29 Cr | 35 Cr |
| Reserves | 44 Cr | 42 Cr | 64 Cr | 55 Cr | 64 Cr | 195 Cr | 659 Cr |
| Borrowings | — | — | — | 9 Cr | 15 Cr | 6 Cr | 29 Cr |
| Other liabilities | — | — | — | 69 Cr | 124 Cr | 206 Cr | 406 Cr |
| Total liabilities | — | — | — | 158 Cr | 228 Cr | 439 Cr | 1,131 Cr |
| Fixed assets (net) | — | — | — | 15 Cr | 24 Cr | 56 Cr | 140 Cr |
| CWIP | — | — | — | 3 Cr | 5 Cr | 6 Cr | 2 Cr |
| Investments | — | — | — | 8 Cr | 5 Cr | 54 Cr | 264 Cr |
| Loans & advances | — | — | — | 7 Cr | 17 Cr | 17 Cr | 37 Cr |
| Inventories | — | — | — | 42 Cr | 54 Cr | 106 Cr | 193 Cr |
| Trade receivables | — | — | — | 28 Cr | 27 Cr | 41 Cr | 74 Cr |
| Cash & bank | — | — | — | 0.09 Cr | 0.68 Cr | 2 Cr | 8 Cr |
| Other assets | — | — | — | 56 Cr | 97 Cr | 158 Cr | 414 Cr |
| Total assets | — | — | — | 158 Cr | 228 Cr | 439 Cr | 1,131 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | 13 Cr | -2 Cr | -6 Cr | -50 Cr | -84 Cr |
| Cash from investing | — | — | -27 Cr | 15 Cr | -13 Cr | -92 Cr | -314 Cr |
| Cash from financing | — | — | 14 Cr | -14 Cr | 19 Cr | 145 Cr | 490 Cr |
| Net cash flow | — | — | 0.95 Cr | -1 Cr | -0.11 Cr | 3 Cr | 92 Cr |
| Free cash flow (OCF − Capex) | — | — | 10 Cr | -15 Cr | -6 Cr | -50 Cr | -84 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | 5.7% | -0.4% | 14.2% | -2.4% | -10.9% | -20.1% | -8.6% |
| ROE % | 4.0% | -0.3% | 9.9% | -7.2% | -15.9% | -24.8% | -10.6% |
| Debtor days | — | — | — | 72 | 55 | 50 | 50 |
| Inventory days | — | — | — | 873 | 1536 | 2371 | 4015 |
| Days payable | — | — | — | 553 | 960 | 951 | 2180 |
| Cash conversion cycle | — | — | — | 393 | 631 | 1470 | 1885 |
| Debt / equity | — | — | — | 0.11 | 0.16 | 0.03 | 0.04 |
| Current ratio | — | — | — | 2.08 | 1.51 | 1.83 | 1.93 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 1.20 | 1.85 | — | 1.13 |